The DOI matches its Crossref record; 409 of the 409 references it cites were found in a registry or an index.
Host-Directed Antiviral Therapy
Open accessAbstract
Antiviral drugs have traditionally been developed by directly targeting essential viral components. However, this strategy often fails due to the rapid generation of drug-resistant viruses. Recent genome-wide approaches, such as those employing small interfering RNA (siRNA) or clustered regularly interspaced short palindromic repeats (CRISPR) or those using small molecule chemical inhibitors targeting the cellular “kinome,” have been used successfully to identify cellular factors that can support virus replication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 409
Sakane, N., Kwon, H.-S., Pagans, S., Kaehlcke, K., Mizusawa, Y., Kamada, M., Lassen, K. G., Chan, J., Greene, W. C., Schnoelzer, M., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002184 · Cited by 111
Inhibition of nuclear export of ribonucleoprotein complexes of influenza virus by leptomycin B
Watanabe, K., Takizawa, N., Katoh, M., Hoshida, K., Kobayashi, N., & Nagata, K. (2001) · Virus Research · doi:10.1016/s0168-1702(01)00263-5 · Cited by 111
Walsh, D., Arias, C., Perez, C., Halladin, D. K., Escandon, M., Ueda, T., Watanabe‐Fukunaga, R., Fukunaga, R., & Mohr, I. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01631-07 · Cited by 110
Characterization of Dengue Virus Resistance to Brequinar in Cell Culture
Qing, M., Zou, G., Wang, Q.-Y., Xu, H. Y., Dong, H., Yuan, Z., & Shi, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00561-10 · Cited by 109
Cytokine Signature Associated with Disease Severity in Dengue
Patro, A. R. K., Mohanty, S., Prusty, B. K., Singh, D. K., Gaikwad, S., Saswat, T., Chattopadhyay, S., Das, B. K., Tripathy, R., & Ravindran, B. (2019) · Viruses · doi:10.3390/v11010034 · Cited by 109
Microbiota and Its Role on Viral Evasion: Is It With Us or Against Us?
Domínguez-Díaz, C., García-Orozco, A., Leal, A. R., Padilla-Arellano, J. R., & Fafutis‐Morris, M. (2019) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2019.00256 · Cited by 109
Blocking eIF4E-eIF4G Interaction as a Strategy To Impair Coronavirus Replication
Cencic, R., Desforges, M., Hall, D. R., Kozakov, D., Du, Y., Min, J., Dingledine, R. J., Fu, H., Vajda, S., Talbot, P. J., et al. (2011) · Journal of Virology · doi:10.1128/jvi.00078-11 · Cited by 108
Atorvastatin does not exhibit antiviral activity against HCV at conventional doses
O’Leary, J. G., Chan, J. L., McMahon, C. M., & Chung, R. T. (2007) · Hepatology · doi:10.1002/hep.21554 · Cited by 107
The potential of the microbiota to influence vaccine responses
Lynn, D. J., & Pulendran, B. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.5mr0617-216r · Cited by 107
A human genome-wide loss-of-function screen identifies effective chikungunya antiviral drugs
Karlas, A., Berrè, S., Couderc, T., Varjak, M., Braun, P. R., Meyer, M., Gangneux, N., Karo-Astover, L., Weege, F., Raftery, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms11320 · Cited by 105
Novel Drugs Targeting Toll-Like Receptors for Antiviral Therapy
Patel, M. C., Shirey, K. A., Pletneva, L. M., Boukhvalova, M. S., Demo, A. G., Vogel, S. N., & Blanco, J. C. G. (2014) · Future Virology · doi:10.2217/fvl.14.70 · Cited by 104
Hutterer, C., Eickhoff, J., Milbradt, J., Korn, K., Zeitträger, I., Bahsi, H., Wagner, S., Zischinsky, G., Wolf, A., Degenhart, C., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04534-14 · Cited by 104
Bajimaya, S., Frankl, T., Hayashi, T., & Takimoto, T. (2017) · Virology · doi:10.1016/j.virol.2017.07.024 · Cited by 104
Liang, Z., Wu, S., Li, Y., Li, H., Wu, M., Jiang, L., Feng, L., Zhang, P., & Huang, X. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023346 · Cited by 102
Alpha-interferon treatment in hepatitis B
Woo, A. S. J., Kwok, R., & Ahmed, T. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.03.69 · Cited by 102
Zeng, B., Li, Z., Chen, R., Guo, N., Zhou, J., Zhou, Q., Lin, Q., Cheng, D., Liao, Q., Zheng, L., et al. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.06.049 · Cited by 101
Patil, V., Guerrant, W., Chen, P. C., Gryder, B. E., Benicewicz, D. B., Khan, S. I., Tekwani, B. L., & Oyelere, A. K. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.10.042 · Cited by 98
Knipe, D. M. (2015) · Virology · doi:10.1016/j.virol.2015.02.009 · Cited by 98
The role of oncogenic kinases in human cancer (Review).
Tsatsanis, C., & Spandidos, D. A. (2000) · International Journal of Molecular Medicine · doi:10.3892/ijmm.5.6.583 · Cited by 98
Direct-acting antivirals and host-targeting strategies to combat enterovirus infections
Bauer, L., Lyoo, H., van der Schaar, H. M., Strating, J. R. P. M., & van Kuppeveld, F. J. M. (2017) · Current Opinion in Virology · doi:10.1016/j.coviro.2017.03.009 · Cited by 98
Hill, J. M., Quenelle, D. C., Cardin, R. D., Vogel, J. L., Clément, C., Bravo, F., Foster, T. P., Bosch‐Marcé, M., Raja, P., Lee, J. S., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3010643 · Cited by 97
Xiao, F., Fofana, I., Thumann, C., Mailly, L., Alles, R., Robinet, É., Meyer, N., Schaeffer, M., Habersetzer, F., Doffoël, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-306155 · Cited by 97
Repurposing of Kinase Inhibitors as Broad-Spectrum Antiviral Drugs
Schor, S., & Einav, S. (2017) · DNA and Cell Biology · doi:10.1089/dna.2017.4033 · Cited by 97
Griffiths, S. J., Koegl, M., Boutell, C., Zenner, H. L., Crump, C. M., Pica, F., Gonzalez, O., Friedel, C. C., Barry, G., Martin, K., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003514 · Cited by 96
Interferon-stimulated genes and their role in controlling hepatitis C virus
Metz, P., Reuter, A., Bender, S., & Bartenschlager, R. F. W. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.033 · Cited by 95
Apigenin Restricts FMDV Infection and Inhibits Viral IRES Driven Translational Activity
Qian, S., Fan, W., Qian, P., et al. (2015) · Viruses · doi:10.3390/v7041613 · Cited by 95
Ehrhardt, C., Rückle, A., Hrincius, E. R., Haasbach, E., Anhlan, D., Ahmann, K., Banning, C., Reiling, S. J., Kühn, J., Strobl, S., et al. (2013) · Cellular Microbiology · doi:10.1111/cmi.12108 · Cited by 94
Nasi, M., Borghi, V., Pinti, M., Bellodi, C., Lugli, E., Maffei, S., Troiano, L., Richeldi, L., Mussini, C., Esposito, R., et al. (2003) · AIDS · doi:10.1097/00002030-200307250-00016 · Cited by 94
Catanese, M. T., Loureiro, J., Jones, C. T., Dorner, M., von Hahn, T., & Rice, C. M. (2013) · Journal of Virology · doi:10.1128/jvi.01102-13 · Cited by 94
Emetine inhibits replication of RNA and DNA viruses without generating drug-resistant virus variants
Khandelwal, N., Chander, Y., Rawat, K. D., Riyesh, T., Nishanth, C., Sharma, S., Jindal, N., Tripathi, B. N., Barua, S., & Kumar, N. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.06.006 · Cited by 94
Self-citationOverview of Direct-Acting Antiviral Drugs and Drug Resistance of Hepatitis C Virus
Li, D. K., & Chung, R. T. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8976-8_1 · Cited by 94
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
Gaither, L. A., Borawski, J. A., Anderson, L. J., Balabanis, K. A., Dévay, P., Joberty, G., Rau, C., Schirle, M., Bouwmeester, T., Mickanin, C., et al. (2009) · Virology · doi:10.1016/j.virol.2009.10.043 · Cited by 93
Mechanisms of Action and Efficacy of Statins against Influenza
Mehrbod, P., Omar, A. R., Bejo, M. H., Haghani, A., & Ideris, A. (2014) · BioMed Research International · doi:10.1155/2014/872370 · Cited by 93
Zhang, K., Cheng, L., Weir, M. D., Bai, Y.-X., & Xu, H. H. (2016) · International Journal of Oral Science · doi:10.1038/ijos.2015.33 · Cited by 92
Uncovering the global host cell requirements for influenza virus replication via RNAi screening
Stertz, S., & Shaw, M. L. (2011) · Microbes and Infection · doi:10.1016/j.micinf.2011.01.012 · Cited by 92
The evolution of life history trade-offs in viruses
Goldhill, D. H., & Turner, P. E. (2014) · Current Opinion in Virology · doi:10.1016/j.coviro.2014.07.005 · Cited by 91
Covid-19: a puzzle with many missing pieces
Vetter, P., Eckerle, I., & Kaiser, L. (2020) · BMJ · doi:10.1136/bmj.m627 · Cited by 91
Zhang, Y., Mao, R., Yan, R., Cai, D., Zhang, Y., Zhu, H., Kang, Y., Liu, H., Wang, J., Qin, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110442 · Cited by 90
Vanwalscappel, B., Tada, T., & Landau, N. R. (2018) · Virology · doi:10.1016/j.virol.2018.07.014 · Cited by 90
Zahid, M., Turek, M., Xiao, F., Thi, V. L. D., Guérin, M., Fofana, I., Bachellier, P., Thompson, J., Delang, L., Neyts, J. H., et al. (2012) · Hepatology · doi:10.1002/hep.26097 · Cited by 89
Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop
Chung, R. T., Gale, M., Polyak, S. J., Lemon, S. M., Liang, J. T., & Hoofnagle, J. H. (2007) · Hepatology · doi:10.1002/hep.22070 · Cited by 89
Milanesi, L., Petrillo, M., Sepe, L., Boccia, A. S., D’Agostino, N., Passamano, M., Nardo, S. D., Tasco, G., Casadio, R., & Paolella, G. (2005) · BMC Bioinformatics · doi:10.1186/1471-2105-6-s4-s20 · Cited by 89
Polysulfonate suramin inhibits Zika virus infection
Tan, C. W., Sam, I., Chong, W. L., Lee, V. S., & Chan, Y. F. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.04.017 · Cited by 89
Danaher, R. J., Jacob, R. J., Steiner, M. R., Allen, W. R., Hill, J. M., & Miller, C. S. (2005) · Journal of NeuroVirology · doi:10.1080/13550280590952817 · Cited by 88
Qing, J., Wang, Y., Sun, Y., Huang, J., Yan, W., Wang, J., Su, D., Ni, C., Li, J., Rao, Z., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004422 · Cited by 87
Entry of influenza viruses into cells is inhibited by a highly specific protein kinase C inhibitor
Root, C. N., Wills, E. G., McNair, L. L., & Whittaker, G. R. (2000) · Journal of General Virology · doi:10.1099/0022-1317-81-11-2697 · Cited by 87
Kennedy, E. M., Courtney, D., Tsai, K., & Cullen, B. R. (2017) · Journal of Virology · doi:10.1128/jvi.02263-16 · Cited by 87
Human Papillomaviruses and the Interferon Response
Beglin, M., Melar-New, M., & Laimins, L. A. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0075 · Cited by 86
Regulation of hepatitis B virus replication by epigenetic mechanisms and microRNAs
Zhang, X., Hou, J., & Lu, M. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00202 · Cited by 86
Receptor Tyrosine Kinase Inhibitors That Block Replication of Influenza A and Other Viruses
Kumar, N., Sharma, N. R., Ly, H., Parslow, T. G., & Liang, Y. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00725-11 · Cited by 86
Self-citationEffect of p38 Mitogen-Activated Protein Kinase on the Replication of Encephalomyocarditis Virus
Hirasawa, K., Kim, A., Han, H.-S., Han, J., Jun, H., & Yoon, J. (2003) · Journal of Virology · doi:10.1128/jvi.77.10.5649-5656.2003 · Cited by 85
Immune Regulation by T Regulatory Cells in Hepatitis B Virus‐Related Inflammation and Cancer
Trehanpati, N., & Vyas, A. K. (2017) · Scandinavian Journal of Immunology · doi:10.1111/sji.12524 · Cited by 85
Quercetin potentiates TNF-induced antiviral activity
Ohnishi, E., & BANNAI, H. (1993) · Antiviral Research · doi:10.1016/0166-3542(93)90041-g · Cited by 84
Bacterial DNA Methylation and Methylomes
Casadesús, J. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-43624-1_3 · Cited by 84
Pillay, D., & Zambon, M. (1998) · BMJ · doi:10.1136/bmj.317.7159.660 · Cited by 83
Ferreira, R. A. X., de Oliveira, S. A., Gandini, M., Ferreira, L. D. C., Corrêa, G., Abiraude, F. M., Reid, M. M., Cruz, O. G., & Kubelka, C. F. (2015) · Acta Tropica · doi:10.1016/j.actatropica.2015.04.023 · Cited by 83
Lavanya, M., Cuevas, C., Thomas, M. G., Cherry, S. R., & Ross, S. R. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006827 · Cited by 83
Sezaki, H., Suzuki, F., Akuta, N., Yatsuji, H., Hosaka, T., Kobayashi, M., Suzuki, Y., Arase, Y., Ikeda, K., Miyakawa, Y., et al. (2009) · Intervirology · doi:10.1159/000213504 · Cited by 82
Mitogen activated protein kinase inhibitors: where are we now and where are we going?
Sweeney, S. E., & Firestein, G. S. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.058388 · Cited by 82
Curcumin Inhibits Rift Valley Fever Virus Replication in Human Cells
Narayanan, A., Kehn‐Hall, K., Senina, S., Lundberg, L., Duyne, R. V., Guendel, I., Das, R., Baer, A., Bethel, L. M., Turell, M. J., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356535 · Cited by 81
The Use of RNAi-Based Screens to Identify Host Proteins involved in Viral Replication
Hirsch, A. J. (2010) · Future Microbiology · doi:10.2217/fmb.09.121 · Cited by 81
Bimbo, L. M., Denisova, O. V., Mäkilä, E. M., Kaasalainen, M. H., Brabander, J. K. D., Hirvonen, J. J., Salonen, J., Kakkola, L., Kainov, D. E., & Santos, H. A. (2013) · ACS Nano · doi:10.1021/nn402062f · Cited by 80
Expression of Toll‐like receptors in chronic hepatitis C virus infection
Sato, K., Ishikawa, T., Okumura, A., Yamauchi, T., Sato, S., Ayada, M., Matsumoto, E., Hotta, N., Oohashi, T., Fukuzawa, Y., et al. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04783.x · Cited by 80
Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway
Pattabhi, S., Wilkins, C. R., Dong, R., Knoll, M. L., Posakony, J., Kaiser, S. M., Mire, C. E., Wang, M. L., Ireton, R. C., Geisbert, T. W., et al. (2015) · Journal of Virology · doi:10.1128/jvi.02202-15 · Cited by 80
Sehrawat, S., & Rouse, B. T. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7636 · Cited by 78
Self-citationMoseley, C. E., Webster, R. G., & Aldridge, J. R. (2010) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2010.00155.x · Cited by 77
Inhibition of Zika Virus Replication by Silvestrol
Elgner, F., Sabino, C., Basic, M., Ploen, D., Grünweller, A., & Hildt, E. (2018) · Viruses · doi:10.3390/v10040149 · Cited by 77
Merino-Ramos, T., Vázquez-Calvo, Á., Casas, J., Sobrino, F., Sáiz, J., & Martín-Acebes, M. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01578-15 · Cited by 76
Emerging Therapeutics Targeting mRNA Translation
Malina, A., Mills, J. R., & Pelletier, J. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a012377 · Cited by 75
Repurposing Kinase Inhibitors as Antiviral Agents to Control Influenza A Virus Replication
Perwitasari, O., Yan, X., O’Donnell, J., Johnson, S. K., & Tripp, R. A. (2015) · Assay and Drug Development Technologies · doi:10.1089/adt.2015.0003.drrr · Cited by 74
Sariol, C. A., Martínez, M. I., Rivera, F., Rodríguez, I. V., Pantoja, P., Abel, K., Arana, T., Giavedoni, L. D., Hodara, V. L., White, L., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019323 · Cited by 74
Synergistic antiviral activity of gemcitabine and ribavirin against enteroviruses
Kang, H., Kim, C., Kim, D., Song, J.-H., Choi, M., Choi, K., Kang, M.-G., Lee, K., Kim, H. S., Shin, J. S., et al. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.10.011 · Cited by 74
Bhat, S., Kabekkodu, S. P., Noronha, A., & Satyamoorthy, K. (2015) · Biochimie · doi:10.1016/j.biochi.2015.12.018 · Cited by 74
Identification of novel antiviral of fungus-derived brefeldin A against dengue viruses
Raekiansyah, M., Mori, M., Nonaka, K., Agoh, M., Shiomi, K., Matsumoto, A., & Morita, K. (2017) · Tropical Medicine and Health · doi:10.1186/s41182-017-0072-7 · Cited by 74
Mitra, B., Thapa, R. J., Guo, H., & Block, T. M. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.08.014 · Cited by 74
Plagues & wars: the ‘Spanish Flu’ pandemic as a lesson from history
Flecknoe, D., Wakefield, B. C., & Simmons, A. (2018) · Medicine Conflict & Survival · doi:10.1080/13623699.2018.1472892 · Cited by 73
Ingiliz, P., Wehmeyer, M. H., Boesecke, C., Wiesch, J. S. Z., Schewe, K., Lutz, T. A., Baumgarten, A., Simon, K., Hueppe, D., Rockstroh, J. K., et al. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz949 · Cited by 73
Ligon, B. L. (2005) · Seminars in Pediatric Infectious Diseases · doi:10.1053/j.spid.2005.07.002 · Cited by 72
Pizzorno, A., Terrier, O., de Lamballerie, C. N., Julien, T., Padey, B., Traversier, A., Roche, M., Hamelin, M., Rhéaume, C., Croze, S., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00060 · Cited by 72
DAS181 Inhibits H5N1 Influenza Virus Infection of Human Lung Tissues
Chan, R. W. Y., Chan, M. C. W., Wong, A. C.-N., Karamanska, R., Dell, A., Haslam, S. M., Sihoe, A. D. L., Chui, W. H., Triana‐Baltzer, G., Li, Q., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00389-09 · Cited by 71
Xiao, X., Lei, X., Zhang, Z., Ma, Y., Qi, J., Wu, C., Xiao, Y., Li, L., He, B., & Wang, J. (2017) · Journal of Virology · doi:10.1128/jvi.00791-17 · Cited by 71
Müller, K. H., Kainov, D. E., Bakkouri, K. E., Saelens, X., Brabander, J. K. D., Kittel, C., Samm, E., & Muller, C. P. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01346.x · Cited by 70
Perturbation of Intracellular Cholesterol and Fatty Acid Homeostasis During Flavivirus Infections
Pombo, J. P. N., & Sanyal, S. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01276 · Cited by 70
Downregulation of Gadd45β Expression by Hepatitis C Virus Leads to Defective Cell Cycle Arrest
Higgs, M. R., Lerat, H., & Pawlotsky, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4554 · Cited by 69
Cloutier, A., Marois, I., Cloutier, D., Verreault, C., Cantin, A. M., & Richter, M. V. (2012) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir804 · Cited by 69
Landovitz, R. J., Angel, J. B., Hoffmann, C., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/592052 · Cited by 69
Phillips, S., Mistry, S., Riva, A., Cooksley, H., Hadzhiolova, T., Plavova, S., Katzarov, K., Simonova, M., Zeuzem, S., Woffendin, C., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00621 · Cited by 69
Recent progress on MAP kinase pathway inhibitors
Uehling, D., & Harris, P. A. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.07.093 · Cited by 68
Zhao, H., Lin, W., Kumthip, K., Du, C., Fusco, D. N., Hofmann, O., Jilg, N., Tai, A. W., Goto, K., Zhang, L., et al. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.07.026 · Cited by 68
LaMarche, M. J., Borawski, J. A., Bose, A., Capacci-Daniel, C., Colvin, R. A., Dennehy, M., Ding, J., Dobler, M., Drumm, J. E., Gaither, L. A., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00946-12 · Cited by 68
Ritchie, D., Piekarz, R., Blombery, P. A., Karai, L., Pittaluga, S., Jaffe, E. S., Raffeld, M. A., Janik, J. E., Prince, H. M., & Bates, S. E. (2009) · Haematologica · doi:10.3324/haematol.2009.008607 · Cited by 67
Annexin A6-Balanced Late Endosomal Cholesterol Controls Influenza A Replication and Propagation
Musiol, A., Gran, S., Ehrhardt, C., Ludwig, S., Grewal, T., Gerke, V., & Rescher, U. (2013) · mBio · doi:10.1128/mbio.00608-13 · Cited by 67
Triana‐Baltzer, G., Babizki, M., Chan, M. C. W., Wong, A. C.-N., Aschenbrenner, L. M., Campbell, E. R., Li, Q., Chan, R. W. Y., Peiris, M. J. S., Nicholls, J. M., et al. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp421 · Cited by 66
The role of microRNAs in hepatitis C virus RNA replication
Conrad, K. D., & Niepmann, M. (2013) · Archives of Virology · doi:10.1007/s00705-013-1883-4 · Cited by 65
Peginterferon and ribavirin treatment for hepatitis C virus infection
Tsubota, A. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i4.419 · Cited by 65
Toll-like Receptor 3 Activation Decreases Porcine Arterivirus Infection
Sang, Y., Ross, C. R., Rowland, R. R. R., & Blecha, F. (2008) · Viral Immunology · doi:10.1089/vim.2008.0042 · Cited by 64
Drug repurposing approaches to fight Dengue virus infection and related diseases
Radi, M. (2017) · Frontiers in bioscience · doi:10.2741/4630 · Cited by 64
AGK2, A SIRT2 Inhibitor, Inhibits Hepatitis B Virus Replication In Vitro And In Vivo
Yu, H., Jiang, H., Cheng, S., Hu, Z., Ren, J., & Chen, J. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.26125 · Cited by 64
Small Molecule Kinase Inhibitors as Anti-Cancer Therapeutics
Chahrour, O., Cairns, D., & Omran, Z. (2012) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955712800493915 · Cited by 61
Martin, S. E., Chiramel, A. I., Schmidt, M. L., Chen, Y.-C., Whitt, N., Watt, A., Dunham, E. C., Shifflett, K., Traeger, S., Leske, A., et al. (2018) · Genome Medicine · doi:10.1186/s13073-018-0570-1 · Cited by 61
Messer, H., Jacobs, D., Dhummakupt, A., & Bloom, D. C. (2015) · Journal of Virology · doi:10.1128/jvi.03052-14 · Cited by 60
Treatment failure in hepatitis C: Mechanisms of non-response
Tai, A. W., & Chung, R. T. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.11.010 · Cited by 59
Epigenetic modulation of host: new insights into immune evasion by viruses
Adhya, D., & Basu, A. (2010) · Journal of Biosciences · doi:10.1007/s12038-010-0072-9 · Cited by 59
Epigenetic inheritance of cell fates during embryonic development
Cheedipudi, S. M., Genolet, O., & Dobreva, G. D. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00019 · Cited by 58
Role of Cellular Lipids in Positive-Sense RNA Virus Replication Complex Assembly and Function
Stapleford, K. A., & Miller, D. J. (2010) · Viruses · doi:10.3390/v2051055 · Cited by 58
Suppression of Astrovirus Replication by an ERK1/2 Inhibitor
Moser, L. A., & Schultz‐Cherry, S. (2008) · Journal of Virology · doi:10.1128/jvi.02193-07 · Cited by 58
Haasbach, E., Müller, C., Ehrhardt, C., Schreiber, A., Pleschka, S., Ludwig, S., & Planz, O. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.03.024 · Cited by 58
Host factors and measles virus replication
Delpeut, S., Noyce, R. S., Siu, R. W. C., & Richardson, C. D. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.10.008 · Cited by 57
The tyrosine kinase inhibitor genistein blocks HIV-1 infection in primary human macrophages
Stantchev, T. S., Markovic, I., Telford, W. G., Clouse, K. A., & Broder, C. C. (2006) · Virus Research · doi:10.1016/j.virusres.2006.09.004 · Cited by 57
Hopcraft, S. E., & Evans, M. J. (2015) · Hepatology · doi:10.1002/hep.27815 · Cited by 57
Molecular principles of human virus protein–protein interactions
Halehalli, R. R., & Nagarajaram, H. A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu763 · Cited by 57
Dhungel, P., Cao, S., & Yang, Z. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006602 · Cited by 56
PRMT5: A novel regulator of Hepatitis B virus replication and an arginine methylase of HBV core
Lubyová, B., Hodek, J., Zábranský, A., Prouzová, H. (., Hubálek, M., Hirsch, I., & Weber, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186982 · Cited by 56
Akt Inhibitor MK2206 Prevents Influenza pH1N1 Virus Infection In Vitro
Denisova, O. V., Söderholm, S., Virtanen, S. I., von Schantz, C., Bychkov, D., Vashchinkina, E., Desloovere, J., Tynell, J., Ikonen, N., Theisen, L. L., et al. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02798-13 · Cited by 55
Kim, Y., & Lee, C. (2015) · Virology · doi:10.1016/j.virol.2015.06.007 · Cited by 54
Vercauteren, K., Eede, N. V. D., Mesalam, A. A., Belouzard, S., Catanese, M. T., Bankwitz, D., Wong‐Staal, F., Cortese, R., Dubuisson, J., Rice, C. M., et al. (2014) · Hepatology · doi:10.1002/hep.27196 · Cited by 54
Large-Scale Screening and Identification of Novel Ebola Virus and Marburg Virus Entry Inhibitors
Anantpadma, M., Kouznetsova, J., Wang, H., Huang, R., Kolokoltsov, A. A., Guha, R., Lindstrom, A., Shtanko, O., Simeonov, A. M., Maloney, D. J., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00543-16 · Cited by 54
Chen, Y., Sze, J., & He, M. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i1.82 · Cited by 53
Dissecting the Role of COPI Complexes in Influenza Virus Infection
Sun, E., He, J., & Zhuang, X. (2012) · Journal of Virology · doi:10.1128/jvi.02277-12 · Cited by 53
Do statins reduce hepatitis C RNA titers during routine clinical use?
Forde, K. A., Law, C., O’Flynn, R., et al. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.5020 · Cited by 53
López‐Huertas, M. R., Jiménez-Tormo, L., Madrid-Elena, N., Gutiérrez, C., Rodríguez-Mora, S., Coiras, M., Alcamí, J., & Moreno, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-02634-y · Cited by 53
Functional Genomic Strategies for Elucidating Human–Virus Interactions
Perreira, J. M., Meraner, P., & Brass, A. L. (2016) · Advances in virus research · doi:10.1016/bs.aivir.2015.11.001 · Cited by 52
Inhibition of poxvirus spreading by the anti-tumor drug Gefitinib (Iressa™)
Langhammer, S., Koban, R., Yue, C., & Ellerbrok, H. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2010.11.006 · Cited by 51
Role of Hypercytokinemia in NF-κB p50-Deficient Mice after H5N1 Influenza A Virus Infection
Droebner, K., Reiling, S. J., & Planz, O. (2008) · Journal of Virology · doi:10.1128/jvi.01071-08 · Cited by 51
Potent Host-Directed Small-Molecule Inhibitors of Myxovirus RNA-Dependent RNA-Polymerases
Krumm, S. A., Ndungu, J. M., Yoon, J.-J., Dochow, M., Sun, A., Natchus, M. G., Snyder, J. P., & Plemper, R. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020069 · Cited by 49
Krishnan, P., Gullen, E. A., Lam, W., Dutschman, G. E., Grill, S. P., & Cheng, Y. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307052200 · Cited by 49
CTCF interacts with the lytic HSV-1 genome to promote viral transcription
Lang, F., Li, X., Vladimirova, O. V., Hu, B., Chen, G., Xiao, Y., Singh, V., Lu, D., Li, L., Han, H., et al. (2017) · Scientific Reports · doi:10.1038/srep39861 · Cited by 49
Host Genetic Influences on Highly Active Antiretroviral Therapy Efficacy and AIDS-Free Survival
Hendrickson, S. L., Jacobson, L. P., Nelson, G. W., Phair, J., Lautenberger, J. A., Johnson, R. C., Kingsley, L., Margolick, J. B., Detels, R., Goedert, J. J., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31816fdc5f · Cited by 48
Badía, R., Angulo, G., Riveira‐Muñoz, E., Pujantell, M., Puig, T., Ramirez, C., Torres‐Torronteras, J., Martí, R., Pauls, E., Clotet, B., et al. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv363 · Cited by 46
Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption
Chang-yi, W., Wong, W.-W., Tsai, H., Chen, Y., Kuo, B.-S., Lynn, S., Blažková, J., Clarridge, K. E., Su, H.-W., Lin, C.-Y., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1802264 · Cited by 46
Host cell mTORC1 is required for HCV RNA replication
Stöhr, S., Costa, R., Sandmann, L., Westhaus, S., Pfaender, S., Anggakusuma, Dazert, E., Meuleman, P., Vondran, F. W. R., Manns, M. P., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308971 · Cited by 45
Identifying HIV-1 host cell factors by genome-scale RNAi screening
Pache, L., König, R., & Chanda, S. K. (2010) · Methods · doi:10.1016/j.ymeth.2010.07.009 · Cited by 45
Nacken, W. K. F., Ehrhardt, C., & Ludwig, S. (2012) · Biological Chemistry · doi:10.1515/hsz-2011-0270 · Cited by 45
Cyclophilin Inhibitors Block Arterivirus Replication by Interfering with Viral RNA Synthesis
de Wilde, A. H., Lǐ, Y., van der Meer, Y., Vuagniaux, G., Łysek, R., Fāng, Y., Snijder, E. J., & van Hemert, M. J. (2012) · Journal of Virology · doi:10.1128/jvi.02078-12 · Cited by 44
Lu, C.-Y., Chang, Y.-C., Hua, C.-H., Chuang, C., Huang, S., Kung, S., Hour, M., & Lin, C. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050954 · Cited by 44
Pan, W., Luo, Q., Yan, X., Yuan, L., Yi, H., Zhang, L., Li, B., Zhang, Y., Sun, J., Qiu, M., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.04.020 · Cited by 44
Post-translational Modification Control of HBV Biological Processes
Yang, F. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02661 · Cited by 44
Kumar, N., Khandelwal, N., Kumar, R., Chander, Y., Rawat, K. D., Chaubey, K. K., Sharma, S., Singh, S. V., Riyesh, T., Tripathi, B. N., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00209 · Cited by 43
Self-citationSato, A., Saito, Y., Sugiyama, K., Sakasegawa, N., Muramatsu, T., Fukuda, S., Yoneya, M., Kimura, M., Ebinuma, H., Hibi∥, T., et al. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24541 · Cited by 42
CRISPR–Cas9 Genetic Analysis of Virus–Host Interactions
Gebre, M. S., Nomburg, J., & Gewurz, B. E. (2018) · Viruses · doi:10.3390/v10020055 · Cited by 42
Ko, E., Kim, S.-J., Joh, J., Park, C.-K., Park, J., & Kim, D.-H. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.06.009 · Cited by 41
Bannister, S., Messina, N. L., Novakovic, B., & Curtis, N. C. (2020) · Epigenetics · doi:10.1080/15592294.2020.1712814 · Cited by 41
Review: Therapeutic implications of hepatitis C virus resistance to antiviral drugs
Pawlotsky, J. (2009) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x09336045 · Cited by 40
Does fluvastatin favour HCV replication in vivo? A pilot study on HIV–HCV coinfected patients
Milazzo, L., Meroni, L., Galazzi, M., Cesari, M., Caramma, I., Marchetti, G. C., Galli, M., & Antinori, S. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01104.x · Cited by 40
Role of ERK1/2 signaling in dengue virus-induced liver injury
Sreekanth, G. P., Chuncharunee, A., Sirimontaporn, A., Panaampon, J., Srisawat, C., Morchang, A., Malakar, S., Thuwajit, P., Kooptiwut, S., Suttitheptumrong, A., et al. (2014) · Virus Research · doi:10.1016/j.virusres.2014.03.025 · Cited by 40
Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against Zika virus
Pitts, J. D., Li, P., de Wispelaere, M., & Yang, P. L. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.10.014 · Cited by 40
A Review of Kinases Implicated in Pancreatic Cancer
Giroux, V., Dagorn, J., & Iovanna, J. (2009) · Pancreatology · doi:10.1159/000199435 · Cited by 39
Amiloride Derivatives Inhibit Coxsackievirus B3 RNA Replication
Harrison, D. N., Gazina, E. V., Purcell, D. F. J., Anderson, D. A., & PETROU, S. P. (2007) · Journal of Virology · doi:10.1128/jvi.01374-07 · Cited by 39
siRNA and shRNA screens advance key understanding of host factors required for HIV-1 replication
Kok, K., Lei, T., & Jin, D. (2009) · Retrovirology · doi:10.1186/1742-4690-6-78 · Cited by 39
Lack of selective resistance of influenza A virus in presence of host-targeted antiviral, UV-4B
Warfield, K. L., Schaaf, K., DeWald, L. E., Spurgers, K. B., Wang, W., Stavale, E. J., Mendenhall, M., Shilts, M. H., Stockwell, T. B., Barnard, D. L., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-43030-y · Cited by 38
COVID-19: A critical care perspective informed by lessons learnt from other viral epidemics
Ling, L., Joynt, G. M., Lipman, J., Constantin, J., & Joannès-Boyau, O. (2020) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2020.02.002 · Cited by 38
Lee, A. S.-Y., Burdeinick-Kerr, R., & Whelan, S. P. J. (2014) · Journal of Virology · doi:10.1128/jvi.00642-14 · Cited by 37
Personalized medicine in severe influenza
Valenzuela-Sánchez, F., Valenzuela-Méndez, B., Gutiérrez, J. F. R., & Rello, J. (2016) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-016-2611-2 · Cited by 37
de Chassey, B., Meyniel-Schicklin, L., Aublin-Gex, A., André, P., & Lotteau, V. (2012) · Molecular Biosystems · doi:10.1039/c2mb05416g · Cited by 36
Covalently closed-circular hepatitis B virus DNA reduction with entecavir or lamivudine
Bowden, S., LOCARNINI, S. A., Chang, T., Chao, Y., Han, K., Gish, R. G., de Man, R. A., Yu, M., Llamoso, C., & Tang, H. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i15.4644 · Cited by 36
Shimizu, Y., Shirasago, Y., Kondoh, M., Suzuki, T., Wakita, T., Hanada, K., Yagi, K., & Fukasawa, M. (2018) · Journal of Virology · doi:10.1128/jvi.02258-17 · Cited by 36
Zhou, L., He, X., Gao, B., & Xiong, S. (2015) · Journal of Virology · doi:10.1128/jvi.01028-15 · Cited by 35
Lenarcic, E. M., Ziehr, B., Leon, G. D., Mitchell, D. A., & Moorman, N. J. (2013) · Journal of Virology · doi:10.1128/jvi.02321-13 · Cited by 35
Drug Resistance in Antiviral Therapy
LOCARNINI, S. A., & Bowden, S. (2010) · Clinics in Liver Disease · doi:10.1016/j.cld.2010.05.004 · Cited by 34
A Host of Factors Regulating Influenza Virus Replication
Mehle, A., & Doudna, J. A. (2010) · Viruses · doi:10.3390/v2020566 · Cited by 34
Toll‐like receptors as novel therapeutic targets for herpes simplex virus infection
Jahanban‐Esfahlan, R., Seidi, K., Majidinia, M., Karimian, A., Yousefi, B., Nabavi, S. M., Astani, A., Berindan‐Neagoe, I., Gulei, D., Fallarino, F., et al. (2019) · Reviews in Medical Virology · doi:10.1002/rmv.2048 · Cited by 34
Schneider, J., & Wolff, T. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.015 · Cited by 33
CRISPR genetic screens to discover host–virus interactions
McDougall, W. M., Perreira, J. M., Reynolds, E. C., & Brass, A. L. (2018) · Current Opinion in Virology · doi:10.1016/j.coviro.2018.03.007 · Cited by 33
Network-Guided Discovery of Influenza Virus Replication Host Factors
Ackerman, E. E., Kawakami, E., Katoh, M., Watanabe, T., Watanabe, S., Tomita, Y., Lopes, T. J. S., Matsuoka, Y., Kitano, H., Shoemaker, J. E., et al. (2018) · mBio · doi:10.1128/mbio.02002-18 · Cited by 33
Novel small molecule Raf kinase inhibitors for targeted cancer therapeutics
Kim, D.-H., & Sim, T. (2012) · Archives of Pharmacal Research · doi:10.1007/s12272-012-0403-5 · Cited by 31
Dynasore Disrupts Trafficking of Herpes Simplex Virus Proteins
Mues, M. B., Cheshenko, N., Wilson, D. W., Gunther-Cummins, L., & Herold, B. C. (2015) · Journal of Virology · doi:10.1128/jvi.00636-15 · Cited by 31
Colao, I., Pennisi, R., Venuti, A., Nygårdas, M., Heikkilä, O., Hukkanen, V., & Sciortino, M. T. (2017) · Scientific Reports · doi:10.1038/s41598-017-09529-y · Cited by 31
Use of Inhibitors in the Study of MAP Kinases
Burkhard, K. A., & Shapiro, P. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-795-2_6 · Cited by 30
Abl Family Tyrosine Kinases Regulate Sialylated Ganglioside Receptors for Polyomavirus
Swimm, A. I., Bornmann, W. G., Jiang, M., Imperiale, M. J., Lukacher, A. E., & Kalman, D. (2010) · Journal of Virology · doi:10.1128/jvi.00129-10 · Cited by 30
Voss, K., Amaya, M., Mueller, C., Roberts, B., Kehn‐Hall, K., Bailey, C., Petricoin, E. F., & Narayanan, A. (2014) · Virology · doi:10.1016/j.virol.2014.09.005 · Cited by 29
Volberding, P. A. (2017) · Europe PMC (PubMed Central) · Cited by 29
RNA editing, epitranscriptomics, and processing in cancer progression
Witkin, K. L., Hanlon, S. E., Strasburger, J. A., Coffin, J. M., Jaffrey, S. R., Howcroft, T. K., Dedon, P. C., STEITZ, J. A., Daschner, P., & Read-Connole, E. (2014) · Cancer Biology & Therapy · doi:10.4161/15384047.2014.987555 · Cited by 28
Kozlov, M. V., Kleymenova, A. A., Konduktorov, K. A., Malikova, A. Z., & Kochetkov, S. N. (2014) · Biochemistry (Moscow) · doi:10.1134/s0006297914070050 · Cited by 28
Vemurafenib Limits Influenza A Virus Propagation by Targeting Multiple Signaling Pathways
Holzberg, M., Boergeling, Y., Schräder, T., Ludwig, S., & Ehrhardt, C. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.02426 · Cited by 28
The dawn of precision medicine in HIV: state of the art of pharmacotherapy
Mu, Y., Kodidela, S., Wang, Y., Kumar, S., & Cory, T. J. (2018) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2018.1515916 · Cited by 28
Advanced Strategies for Eliminating the cccDNA of HBV
Dong, J., Ying, J., Qiu, X., Lu, Y., & Zhang, M. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4842-1 · Cited by 27
Pharmacological Inhibition of Protein Kinase C Reduces West Nile Virus Replication
Blázquez, A.-B., Vázquez-Calvo, Á., Martín-Acebes, M. A., & Sáiz, J. (2018) · Viruses · doi:10.3390/v10020091 · Cited by 27
Halota, W., Ferenci, P., Kozielewicz, D., Dybowska, D., Lisovoder, N., Samira, S., Shalit, I., Ellis, R., & Ilan, Y. (2014) · Journal of Viral Hepatitis · doi:10.1111/jvh.12369 · Cited by 26
Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection
Maughan, A., & Ogbuagu, O. E. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1421173 · Cited by 26
Life cycle synchronization is a viral drug resistance mechanism
Neagu, I. A., Olejarz, J. W., Freeman, M., Rosenbloom, D. I. S., Nowak, M. A., & Hill, A. L. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005947 · Cited by 26
p38 Mitogen-Activated Protein Kinase Inhibitors: A Review on Pharmacophore Mapping and QSAR Studies
Gangwal, R. P., Bhadauriya, A., Damre, M. V., Dhoke, G. V., & Sangamwar, A. T. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313090005 · Cited by 25
Klotz, D., & Gerhauser, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071620 · Cited by 25
A broad antiviral neutral glycolipid, fattiviracin FV-8, is a membrane fluidity modulator
Harada, S., Yokomizo, K., Monde, K., Maeda, Y., & Yusa, K. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00781.x · Cited by 24
Woelk, C. H., Beliakova‐Bethell, N., Goicoechea, M., Zhao, Y., Du, P., Rought, S. E., Lozach, J., Pérez‐Santiago, J., Richman, D. D., Smith, D. M., et al. (2009) · AIDS · doi:10.1097/qad.0b013e328334f1f0 · Cited by 22
The c-Jun N-terminal kinase inhibitor SP600125 inhibits human cytomegalovirus replication
Zhang, H., Niu, X., Qian, Z., Qian, J., & Xuan, B. (2015) · Journal of Medical Virology · doi:10.1002/jmv.24286 · Cited by 21
Schlesinger, M. J., & Cahill, D. (1989) · Virology · doi:10.1016/0042-6822(89)90421-2 · Cited by 21
A common, non-optimal phenotypic endpoint in experimental adaptations of bacteriophage lysis time
Chantranupong, L., & Heineman, R. H. (2012) · BMC Evolutionary Biology · doi:10.1186/1471-2148-12-37 · Cited by 21
Treatment of Hepatitis C Infections with Interferon: A Historical Perspective
Friedman, R. M., & Contente, S. (2010) · Hepatitis Research and Treatment · doi:10.1155/2010/323926 · Cited by 19
Nousiainen, L., Sillanpää, M., Jiang, M., Thompson, J., Taipale, J., & Julkunen, I. (2013) · Innate Immunity · doi:10.1177/1753425912473345 · Cited by 19
Interferon-Stimulated Genes Response in Endothelial Cells Following Hantaan Virus Infection
Kim, I.-W., Hwang, J. Y., Kim, S.-K., Kim, J.-K., & Park, H.-S. (2007) · Journal of Korean Medical Science · doi:10.3346/jkms.2007.22.6.987 · Cited by 19
Saito, H., Tada, S., Ebinuma, H., Ishii, H., Kashiwazaki, K., Takahashi, M., Tsukada, N., Nishida, J., Tanaka, S., Shiozaki, H., et al. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.00079-06 · Cited by 19
Liu, X., Yang, Y., Zhao, M., Bode, L., Zhang, L., Pan, J., Lv, L., Zhan, Y., Liu, S., Zhang, L., et al. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.03.009 · Cited by 18
Stimulation of alpha2-adrenergic receptors impairs influenza virus infection
Matsui, K., Ozawa, M., Kiso, M., Yamashita, M., Maekawa, T., Kubota, M., Sugano, S., & Kawaoka, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-22927-0 · Cited by 18
Host Factors Involved in Ebola Virus Replication
Rasmussen, A. L. (2017) · Current topics in microbiology and immunology · doi:10.1007/82_2017_27 · Cited by 17
Wang, F., Shen, F., Wang, Y., Li, Z., Chen, J., & Yuan, Z. (2019) · Virology · doi:10.1016/j.virol.2019.10.009 · Cited by 17
Effect of a Histone Demethylase Inhibitor on Equine Herpesvirus-1 Activity In Vitro
Tallmadge, R. L., Žygelytė, E., de Walle, G. R. V., Kristie, T. M., & Felippe, M. J. B. (2018) · Frontiers in Veterinary Science · doi:10.3389/fvets.2018.00034 · Cited by 15
Osinusi, A. O., Rasimas, J. J., Bishop, R. J., Proschan, M. A., McLaughlin, M. E., Murphy, A., Cortez, K. J., Polis, M. A., Masur, H., Rosenstein, D. L., et al. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181c7a29d · Cited by 13
Systems Perspective of Morbillivirus Replication
Kumar, N., Barua, S., Thachamvally, R., & Tripathi, B. N. (2016) · Microbial Physiology · doi:10.1159/000448842 · Cited by 13
Self-citationAnalysis of the Human Kinome Using Methods Including Fold Recognition Reveals Two Novel Kinases
Briedis, K. M., Starr, A., & Bourne, P. E. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001597 · Cited by 12
Jones, B. G., Hayden, R. T., & Hurwitz, J. L. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.09.014 · Cited by 12
Cited by
An Overview of the Recent Advances in Antimicrobial Resistance
Oliveira, M., Antunes, W., Mota, S., Madureira-Carvalho, Á., Dinis-Oliveira, R. J., & Dias da Silva, D. (2024) · Microorganisms · doi:10.3390/microorganisms12091920 · Cited by 285
Synergistic Effects Between Metal Nanoparticles and Commercial Antimicrobial Agents: A Review
Ribeiro, A. I., Dias, A. M., & Zille, A. (2022) · ACS Applied Nano Materials · doi:10.1021/acsanm.1c03891 · Cited by 276
Lawrenz, J., Wettstein, L., Rodríguez Alfonso, A., Nchioua, R., von Maltitz, P., Albers, D. P. J., Zech, F., Vandeput, J., Naesens, L., Fois, G., et al. (2025) · Advanced Science · doi:10.1002/advs.202506430 · Cited by 8
Metadata
- Authors
- Kumar, N., Sharma, S., Kumar, R., Tripathi, B. N., Barua, S., Ly, H., & Rouse, B. T.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2020-06-17
- Volume
- 33
- Issue
- 3
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W3024562929
- Cited by
- 271
- References
- 409
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.